Over 70% of potential research participants live >2 hours away from sites, & patient drop-out rates can reach 30% depending on the therapeutic area.
The Solution: eConsent
Why?
- Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting.
- Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.
This white paper is sponsored by Medable .
A valid email address is required to receive a copy of this PDF.